Constitutive Activation converts rtKs to Dominant Acting Oncogenes Images removed due to copyright reasons Please see Figure 2 in Zwick, E, J. Bange and A Ulrich Receptor Tyrosine Kinases as Targets for Anticancer Drugs Trends Mol Med. 8, no. 1(Jan 2002): 17-23Constitutive Activation converts RTKs to Dominant Acting Oncogenes Images removed due to copyright reasons. Please see Figure 2 in Zwick, E., J. Bange and A. Ullrich. Trends Mol Med. 8, no. 1 (Jan 2002):17-23. "Receptor Tyrosine Kinases as Targets for Anticancer Drugs